Scout Investments’s NeoGenomics NEO Stock Holding History

Scout Investments’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-267,572	Closed	-$2.47M	–	213
2022 Q4	$2.47M	Sell	267,572 -4,449	-2%	-$41.5K	0.05%	202
2022 Q3	$2.34M	Sell	272,021 -7,660	-3%	-$76.1K	0.05%	215
2022 Q2	$2.28M	Buy	279,681 +7,958	+3%	+$76K	0.05%	213
2022 Q1	$3.3M	Sell	271,723 -345	-0.1%	-$7.26K	0.05%	219
2021 Q4	$9.28M	Sell	272,068 -6,126	-2%	-$240K	0.13%	198
2021 Q3	$13.4M	Sell	278,194 -4,612	-2%	-$214K	0.2%	151
2021 Q2	$12.8M	Buy	282,806 +41,995	+17%	+$1.86M	0.19%	163
2021 Q1	$11.6M	Buy	240,811 +23,788	+11%	+$1.24M	0.17%	185
2020 Q4	$11.7M	Buy	217,023 +6,000	+3%	+$271K	0.21%	181
2020 Q3	$7.79M	Buy	211,023 +36,070	+21%	+$1.34M	0.17%	194
2020 Q2	$5.42M	Buy	+174,953	New	+$4.85M	0.13%	216

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Scout Investments's NEO Position: Q1 2023 in Review

Scout Investments sold out of NeoGenomics (NEO) in Q1 2023, closing a stake of 267,572 shares — an estimated $2.47M sold.

Scout Investments first reported a position in NEO in Q2 2020 and held it in 11 quarters. The position peaked at $13.4M in Q3 2021. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2023.

Scout Investments reported no remaining NeoGenomics position as of Q1 2023 after selling out during the quarter.
Scout Investments sold 267,572 NeoGenomics shares in Q1 2023, an estimated $2.47M.
Scout Investments first reported a position in NeoGenomics in Q2 2020 and held it in 11 quarters.
Scout Investments's NeoGenomics position peaked at $13.4M in Q3 2021.
256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2023.

Based on Scout Investments's 13F filing for Q1 2023, filed 11 May 2023.